European Proceedings Logo

Diet And Physiotherapy In The Treatment Of Obesity And Its Comorbidities

Table 1:

No. Age H IW FW BMI Associated disorders Comorbidities evolution
I F
1 21 171 95 84 34 28.6 Hypercholesterolemia Improved
2 27 174 102 93 33.7 30.7 IBS; Slow intestinal transit Improved
3 32 171 93 85 31.6 29 Constipation Improved
4 36 168 90 82 31.9 29 Hypothyroidism Unchanged
5 38 166 105 93 38 33.8 Hyperuricemia Improved
6 41 169 98 91 34.3 32 Asthma Improved
7 42 164 114 105 42.4 39 Hypercholesterolemia Improved
8 46 161 89 83 34.3 32 Dyslipidaemia Improved
9 49 165 91 86 33.4 31.6 Diabetes;Circulatory Disorders Improved
10 54 158 102 95 41 38 Dyslipidaemia; Varix Improved
11 35 160 85 80 33.4 30 Slow intestinal transit Improved
12 60 157 115 103 45 40 Osteoporosis; Diabetes Unchanged
13 55 162 90 84 41 39 Varix Improved
14 33 153 70 60 30 26.3 Hypothyroidism Unchanged
15 75 171 94 84 40 35 Hypercholesterolemia Improved
16 64 168 103 90 41.3 38 IBS Improved
17 42 183 130 101 38.8 30 Slow intestinal transit Improved
18 39 180 120 115 39 35 Dyslipidaemia Improved
19 29 160 89 70 31 28.2 Thrombophlebitis Unchanged
20 27 165 93 77 33 30 BARDET-BIEDL Syndrome Unchanged
21 58 169 104 96 40 37.2 Hypertension; Diabetes; Circulatory disorders Improved
22 72 160 95 90 39.4 33.3 Hyperuricemia Improved
23 80 167 82 78 43.1 38.5 Asthma Unchanged
24 39 172 98 88 36.9 30.4 Circulatory Disorders; Asthma Improved
25 23 164 80 70 34 31.1 Slow intestinal transit Improved
26 30 170 95 86 32.7 29 Dyslipidaemia Improved
27 33 172 100 81 32.5 29.3 Hypertension; Circulatory Disorders Improved
28 47 163 113 97 34.4 31.7 Hypercholesterolemia Improved
29 42 170 100 90 35 29 Hypertension Improved
30 48 174 123 103 39.7 30.2 Hypothyroidism Unchanged
< Back to article